✦ LIBER ✦

Improved Outcome After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplant (RI-HCT) For MDS Using Tacrolimus/Sirolimus As GVHD Prophylaxis

✍ Scribed by R. Nakamura; J. Palmer; J. Chao; T. Stiller; V. Pullarkat; P. Parker; A. Stein; D. Snyder; J.-L. Cai; R. Bhatia; K. Chang; S. Wang; D. Senitzer; S.J. Forman; M.R. O'Donnell

Book ID: 116281554
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 66 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.12.355

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced intensity allogeneic hematopoiet

Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis

✍ Ryotaro Nakamura; Joycelynne M. Palmer; Margaret R. O’Donnell; Tracey Stiller; S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Improved Outcomes Using Tacrolimus/Sirol

Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis

✍ David S. Snyder; Joycelynne Palmer; Karl Gaal; Anthony S. Stein; Vinod Pullarkat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Tacrolimus and Sirolimus as GVHD Prophyl

Tacrolimus and Sirolimus as GVHD Prophylaxis for Sibling Donor Hematopoietic Stem Cell Transplant (HCT) Using Three Conditioning Regimens; Fludarabine-Melphalan, FTBI-VP16, and Busulfan-Cyclophosphamide

✍ R. Nakamura; R. Rodriguez; J. Palmer; P. Parker; A. Nademanee; S. Shayani; E. Sm 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB